Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

[Beta adrenergic receptors in patients with untreated and verapamil-treated hypertrophic cardiomyopathy].

Kölbel F, Krulík R, Slíva D, Hradec J, Aschermann M, Simper D, Schreiber V.

Sb Lek. 1988 Jul;90(7):218-22. Czech. No abstract available.

PMID:
2851875
2.

Verapamil in the treatment of hypertrophic cardiomyopathy.

Rosing DR, Epstein SE.

Ann Intern Med. 1982 May;96(5):670-2. No abstract available.

PMID:
6122414
3.

Verapamil and norverapamil plasma concentrations during long-term therapy in patients with hypertrophic obstructive cardiomyopathy.

Woodcock BG, Hopf R, Kaltenbach M.

J Cardiovasc Pharmacol. 1980 Jan-Feb;2(1):17-23. No abstract available.

PMID:
6154201
4.

Verapamil therapy in infants with hypertrophic cardiomyopathy.

Moran AM, Colan SD.

Cardiol Young. 1998 Jul;8(3):310-9.

PMID:
9731645
5.

Use of calcium channel blockers in hypertrophic cardiomyopathy.

Lorell BH.

Am J Med. 1985 Feb 22;78(2B):43-54.

PMID:
4038850
6.

Verapamil improves the pacing-induced vasodilatation in symptomatic patients with hypertrophic cardiomyopathy.

Dimitrow PP, Krzanowski M, Grodecki J, Małecka B, Lelakowski J, Kawecka-Jaszcz K, Szczeklik A, Dubiel JS.

Int J Cardiol. 2002 Jun;83(3):239-47.

PMID:
12036528
7.

Use of verapamil in the treatment of hypertrophic cardiomyopathy.

Gregor P, Widimský P, Cervenka V, Vísek V, Sládková T, Dvorák J.

Cor Vasa. 1986;28(6):404-12.

PMID:
3829686
8.

[Do guide lines for differential therapy in hypertrophic obstructive cardiomyopathy exits?].

Kaltenbach M, Hopf R, Bussmann WD, Kober G, Petersen Y, Keller M.

Cardiology. 1978;63 Suppl 1:77-9. German. No abstract available.

PMID:
28845
9.

Verapamil-induced ventricular tachycardia in hypertrophic cardiomyopathy.

Wessel A, Seiffert P, Dettmann R, Heintzen PH.

Eur Heart J. 1987 Mar;8(3):313-5.

PMID:
3582389
10.

[Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].

Korovina EP.

Klin Med (Mosk). 1998;76(12):30-5. Russian.

PMID:
10067289
11.
12.

Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy.

Perrot B, Danchin N, Terrier de la Chaise A.

Br Heart J. 1984 Mar;51(3):352-4.

13.

Obstructive hypertrophic cardiomyopathy with left-sided cardiac failure: improvement after verapamil treatment.

Eldar M, Hod H, Battler A, Rotstein Z, Feldman S, Rabinowitz B, Neufeld HN.

Am J Cardiol. 1984 Feb 1;53(4):644-5. No abstract available.

PMID:
6538062
14.
15.

Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy.

Masini V, Ceci V, Malinconico U, Milazzotto F.

G Ital Cardiol. 1981;11(11):1729-37. Review. No abstract available.

PMID:
7044864
16.

Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function.

Anderson DM, Raff GL, Ports TA, Brundage BH, Parmley WW, Chatterjee K.

Br Heart J. 1984 May;51(5):523-9.

17.

Diastolic function in hypertrophic cardiomyopathy: effects of propranolol and verapamil on diastolic stiffness.

Hess OM, Grimm J, Krayenbuehl HP.

Eur Heart J. 1983 Nov;4 Suppl F:47-56.

PMID:
6686544
18.

Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy.

Wilmshurst PT, Thompson DS, Juul SM, Jenkins BS, Webb-Peploe MM.

Br Heart J. 1986 Dec;56(6):544-53.

19.

Long-term treatment of hypertrophic obstructive cardiomyopathy--usefulness of verapamil.

Kober G, Schmidt-Moritz A, Hopf R, Kaltenbach M.

Eur Heart J. 1983 Nov;4 Suppl F:165-74. No abstract available.

PMID:
6686532

Supplemental Content

Support Center